Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry globally. The company offers a diverse product portfolio including cell lines, cell culture media, bioreactors, reagents, and advanced therapies. It also provides products for separation, purification, and concentration processes, alongside systems for storing and transporting intermediate and finished biological products. Key offerings extend to fluid management services, biolayer interferometry instruments, and microbiology testing, sterility testing, and air monitoring instruments. The company also supplies pipette products, sensors and analyzers, screening instruments, biomolecule analysis tools, batch liquid chromatography systems, and lab data and fleet management software. Further products include live cell imaging and analysis, surface plasmon resonance solutions, water purification systems, and weighing products. Sartorius Stedim Biotech S.A. also provides data analytics software, a process automation platform and software, and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focused on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to address oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. Its customer base includes manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. Incorporated in 1978, the company is headquartered in Aubagne, France, and operates as a subsidiary of Sartorius AG.